Celltrion reported 178% revenue growth in 4Q24. The company guided for 2025 revenue of KRW5.0T, up 43% YoY. Operating profit margin is expected to recover to 30% range in 2025.
What is covered in the Full Insight:
Record High Quarterly Revenue
Expansion of New Products
Sequential Decline in Profitability
Preparedness for US Tariff Risks
Innovative Drug Pipeline
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.